---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-061371"
form_type: "8-K"
ticker: "SCLX"
cik: "0001820190"
company_name: "Scilex Holding Co"
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:31:15.350504+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Scilex issues warrant to Oramed for 100,000 shares at $20.00 in exchange for payment deferral

## Summary
- Warrant for 100,000 shares at $20.00 issued to Oramed Pharmaceuticals for deferring an amortization payment originally due Oct 1, 2025.
- Deferred payment was made in November 2025; warrant is immediately exercisable and expires Dec 13, 2029.
- Exercise price subject to anti-dilution adjustments with a floor of $8.22; beneficial ownership limit set at 4.99%.
- Company commits to file a resale registration statement for the underlying shares within 30 days or by March 31, 2026.
- Warrant agreement includes most-favored-nations clause for six months and standard change-of-control repurchase right.

## SEC filing metadata
- accession: 0001193125-26-061371
- form_type: 8-K
- ticker: SCLX
- cik: 0001820190
- company_name: Scilex Holding Co
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/0001193125-26-061371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/sclx-20260219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-061371
- JSON: https://secwatch.observer/filing/0001193125-26-061371.json
- Plain text: https://secwatch.observer/filing/0001193125-26-061371.txt

## Key facts
- Material Agreements
  Scilex Holding Co entered into Warrant Agreement with Oramed Pharmaceuticals Inc. (effective 2026-02-19).
  - Action: entry
  - Counterparty: Oramed Pharmaceuticals Inc.
  - Effective: 2026-02-19
  source text: On February 19, 2026, Scilex Holding Company (the “ Company ”) entered into a Warrant Agreement (the “ Warrant Agreement ”) with Oramed Pharmaceuticals Inc. (“ Oramed ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/0001193125-26-061371-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.